Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MasterCard Inc (MA) vs GeneDx Holdings Corp (WGS) Price & Performance

MasterCard IncTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

MasterCard Inc vs GeneDx Holdings Corp — how do they compare? MasterCard Inc trades at $560.5 (market cap $491.83B), while GeneDx Holdings Corp trades at $82.25 (market cap $2.44B). The key difference: MasterCard Inc is far larger — about 201.6× GeneDx Holdings Corp's market cap, and MasterCard Inc pays a 0.62% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

MAWGS
Market Cap
$491.83B$2.44B
Volume
4,635,698
Sector
Consumer CyclicalTechnology
52-Week High
$598.96$167.51
52-Week Low
$471.55$34.51
Enterprise Value
$504.86B$2.48B
Dividend Yield
0.62%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MasterCard Inc

Mastercard (MA) trades at $559.88, down 0.58% today, with strong technical support at $559 and resistance at $566. The stock shows robust fundamentals, with Q2 2026 EPS beating expectations at $5.04 versus $4.77, and revenue growth accelerating to $32.79B in 2025. Analysts maintain a bullish consensus, with 79% buy ratings and a $660.85 price target, while institutional buying activity remains positive, as noted in recent SEC filings.

Outlook is positive due to consistent earnings beats, high profitability margins, and strategic initiatives in digital payments and AI. Risks include competition from emerging payment technologies like stablecoins, as highlighted by The Motley Fool on April 10, 2026, and elevated valuation multiples such as a P/E of 30.88, which may limit near-term upside if growth slows.

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.

Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About MasterCard Inc

Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.

Read more on MA

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS